Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 10,558.7%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 10,558.68% |
Abivax SA American Depositary Shares (ABVX) | 997.1% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 792.4% |
BitMine Immersion Technologies (BMNR) | 534.9% |
TMC the metals (TMC) | 365.79% |
Celcuity LLC (CELC) | 277.91% |
ViaSat (VSAT) | 269.32% |
Pagaya Technologies (PGY) | 264.98% |
Polestar Automotive Holding UK PLC Class C-1 ADS (ADW) (PSNYW) | 221.04% |
CommScope (COMM) | 206.65% |
Centrus Energy (LEU) | 193.68% |
SSR Mining (SSRM) | 161.93% |
Sharplink Gaming (SBET) | 150.91% |
IHS (IHS) | 147.6% |
Opendoor Technologies (OPEN) | 147.38% |
Tutor Perini (TPC) | 140.16% |
Ascentage Pharma Group International (AAPG) | 140% |
Liquidia Technologies (LQDA) | 137.09% |
Dave (DAVE) | 135.51% |
Sibanye Gold Ltd ADR (SBSW) | 130.5% |
New Gold (NGD) | 126.69% |
Verona Pharma PLC ADR (VRNA) | 126.41% |
Life360, Inc Common Stock (LIF) | 117.6% |
Energy Fuels (UUUU) | 117.14% |
IREN (IREN) | 116.83% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
